Feng Bai

791 total citations
32 papers, 609 citations indexed

About

Feng Bai is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Feng Bai has authored 32 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Molecular Biology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Feng Bai's work include Sexual function and dysfunction studies (4 papers), Cardiovascular Function and Risk Factors (4 papers) and Blood Pressure and Hypertension Studies (4 papers). Feng Bai is often cited by papers focused on Sexual function and dysfunction studies (4 papers), Cardiovascular Function and Risk Factors (4 papers) and Blood Pressure and Hypertension Studies (4 papers). Feng Bai collaborates with scholars based in China. Feng Bai's co-authors include Junwei Yang, Hao Ding, Yuan Qi, Lei Jiang, Ke Zen, Yang Zhou, Jing Luo, Jing Xu, Shao-Gang Ma and Wen Hu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Dental Research and Journal of Cellular Physiology.

In The Last Decade

Feng Bai

29 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Bai China 14 226 144 98 93 84 32 609
Yi-Jen Hung Taiwan 14 243 1.1× 130 0.9× 146 1.5× 71 0.8× 99 1.2× 30 708
Danuta Fedak Poland 15 140 0.6× 84 0.6× 106 1.1× 101 1.1× 64 0.8× 43 615
Zhihong Zhang China 13 159 0.7× 79 0.5× 55 0.6× 55 0.6× 105 1.3× 28 596
Seung Jun Kim South Korea 10 141 0.6× 105 0.7× 75 0.8× 34 0.4× 98 1.2× 20 576
Pedro Rozas-Moreno Spain 13 376 1.7× 190 1.3× 92 0.9× 84 0.9× 97 1.2× 32 879
Xiang Hu China 14 257 1.1× 157 1.1× 64 0.7× 126 1.4× 163 1.9× 32 615
Jiandong Zhang China 14 132 0.6× 192 1.3× 61 0.6× 156 1.7× 60 0.7× 22 651
Ju-Young Moon South Korea 14 168 0.7× 136 0.9× 183 1.9× 128 1.4× 36 0.4× 30 584
Chin‐Sung Kuo Taiwan 14 206 0.9× 135 0.9× 82 0.8× 104 1.1× 85 1.0× 50 657
Lung‐Chih Li Taiwan 17 269 1.2× 139 1.0× 205 2.1× 92 1.0× 104 1.2× 44 910

Countries citing papers authored by Feng Bai

Since Specialization
Citations

This map shows the geographic impact of Feng Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Bai more than expected).

Fields of papers citing papers by Feng Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Bai. The network helps show where Feng Bai may publish in the future.

Co-authorship network of co-authors of Feng Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Bai. A scholar is included among the top collaborators of Feng Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Bai. Feng Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qiongying, et al.. (2025). Astragaloside IV Alleviates H 2 O 2 ‐Induced Mitochondrial Dysfunction and Inhibits Mitophagy Via PI3K/AKT/mTOR Pathway. Cardiovascular Therapeutics. 2025(1). 9549175–9549175. 1 indexed citations
2.
Zhou, Feng, Zhanqi Wang, Daowen Wang, et al.. (2024). USP7 Inhibition Promotes Early Osseointegration in Senile Osteoporotic Mice. Journal of Dental Research. 104(1). 86–96. 5 indexed citations
3.
Huo, Yan, Wei Wang, Jing Zhang, et al.. (2023). Maternal androgen excess inhibits fetal cardiomyocytes proliferation through RB-mediated cell cycle arrest and induces cardiac hypertrophy in adulthood. Journal of Endocrinological Investigation. 47(3). 603–617. 1 indexed citations
4.
Liao, Jiaxin, et al.. (2023). Serum Isthmin-1 Was Increased in Type 2 Diabetic Patients but Not in Diabetic Sensorimotor Peripheral Neuropathy. Diabetes Metabolic Syndrome and Obesity. Volume 16. 2013–2024. 7 indexed citations
5.
6.
Wang, Shixiong, Ping Wang, Lingling Jin, et al.. (2019). <p>The potential role of testosterone in hypertension and target organ damage in hypertensive postmenopausal women</p>. Clinical Interventions in Aging. Volume 14. 743–752. 5 indexed citations
7.
Peng, Wenfang, Feng Bai, Kan Shao, et al.. (2018). The key genes underlying pathophysiology association between the type 2‐diabetic and colorectal cancer. Journal of Cellular Physiology. 233(11). 8551–8557. 28 indexed citations
8.
Sun, Shougang, et al.. (2018). Local delivery of thalidomide to inhibit neointima formation in rat model with artery injury. Pathology - Research and Practice. 214(9). 1303–1308. 3 indexed citations
9.
Yu, Yanting, Feng Bai, Nan Qin, et al.. (2018). Non-Proximal Renal Tubule-Derived Urinary Exosomal miR-200b as a Biomarker of Renal Fibrosis. ˜The œNephron journals/Nephron journals. 139(3). 269–282. 48 indexed citations
10.
11.
Ding, Hao, Lei Jiang, Jing Xu, et al.. (2017). Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis. American Journal of Physiology-Renal Physiology. 313(3). F561–F575. 201 indexed citations
12.
Zhao, Kun, et al.. (2016). Clinical Practice Guidelines for Hypertension: Evaluation of Quality Using the AGREE II Instrument. American Journal of Cardiovascular Drugs. 16(6). 439–451. 11 indexed citations
13.
Wang, Qiongying, Xu Han, Mina Yang, et al.. (2015). Tetrahydrobiopterin reverse left ventricular hypertrophy and diastolic dysfunction through the PI3K/p-Akt pathway in spontaneously hypertensive rats. Biochemical and Biophysical Research Communications. 463(4). 1012–1020. 15 indexed citations
14.
Tian, Shouqin, et al.. (2015). Endothelial cell-targeted pVEGF165 polyplex plays a pivotal role in inhibiting intimal thickening after vascular injury. International Journal of Nanomedicine. 10. 5751–5751. 5 indexed citations
15.
Xu, Wei, Haifeng Wu, Shao-Gang Ma, et al.. (2013). Correlation between Peripheral White Blood Cell Counts and Hyperglycemic Emergencies. International Journal of Medical Sciences. 10(6). 758–765. 45 indexed citations
16.
17.
18.
Ma, Shao-Gang, et al.. (2012). Ischemia-modified albumin in patients with hyperthyroidism and hypothyroidism. European Journal of Internal Medicine. 23(6). e136–e140. 14 indexed citations
19.
Ma, Shao-Gang, Yue Jin, Wei Xu, et al.. (2012). Increased serum levels of ischemia-modified albumin and C-reactive protein in type 1 diabetes patients with ketoacidosis. Endocrine. 42(3). 570–576. 30 indexed citations
20.
Lin, Xin, et al.. (2011). Effect of felodipine with irbesartan or metoprolol on sexual function and oxidative stress in women with essential hypertension. Journal of Hypertension. 30(1). 210–216. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi-Jen Hung Breakdown of academic impact, for papers by Danuta Fedak Breakdown of academic impact, for papers by Zhihong Zhang Breakdown of academic impact, for papers by Seung Jun Kim Breakdown of academic impact, for papers by Pedro Rozas-Moreno Breakdown of academic impact, for papers by Xiang Hu Breakdown of academic impact, for papers by Jiandong Zhang Breakdown of academic impact, for papers by Ju-Young Moon Breakdown of academic impact, for papers by Chin‐Sung Kuo Breakdown of academic impact, for papers by Lung‐Chih Li
Rankless by CCL
2026